Summary
A bioRxiv preprint reports that transplanted hearts rapidly assimilated recipients’ biological age in mouse experiments and patient analyses. The effect was detected in graft tissue, not as a change in the recipient’s systemic biological age.
A bioRxiv preprint reports that transplanted hearts can rapidly align with the recipient’s biological age. The finding emerged from experiments in mice and analyses of transplant patients, with the graft’s biological-age measures more strongly associated with the recipient than with the donor.
The effect was confined to the transplanted heart tissue. The researchers found no reciprocal change in the recipient’s systemic biological age. Their results appeared in DNA methylation, gene-expression and functional analyses, suggesting that signals from the recipient’s body may influence the biological state of the graft.
How the researchers studied biological age after transplantation
The study examined heterochronic transplants, in which donor and recipient differ in age. This is relevant to transplantation because organs are frequently moved between people with substantial age differences, while a shortage of donor organs limits the ability to match donors and recipients closely by age.
The researchers combined multiomic profiling with biomarkers of aging. Multiomic analysis examines several layers of biological information, while aging biomarkers estimate biological age from molecular or functional features rather than from calendar age alone. The study specifically identified effects at the level of DNA methylation and gene expression. DNA methylation consists of chemical marks that can influence gene activity and vary with cell state and age; gene-expression measurements indicate which genes are more or less active.
The work first assessed experimental heart transplants in mice. It then extended the analysis to patients who had received hearts from donors of a different age, using molecular and functional measurements to examine the relationship between graft age, donor age and recipient age.
Recipient age was the stronger signal in transplanted hearts
In the mouse experiments, the biological age of transplanted hearts rapidly assimilated the age of the recipient. The change was limited to the grafted tissue: the recipient’s broader, systemic biological age did not show a reciprocal shift.
The molecular results supported this pattern. Both DNA-methylation measurements and gene-expression data indicated that the transplanted heart was responding to its new biological environment. In the clinical analysis, the biological age of transplanted hearts was strongly associated with the recipient’s age rather than the donor’s age. Functional analyses also supported the clinical relevance of the molecular findings.
The result does not mean that chronological age is erased from a transplanted organ. Rather, it indicates that biological-age signals in heart tissue can change after transplantation and may be shaped substantially by the recipient’s systemic environment.
Why the finding matters for organ allocation
The authors identify the systemic environment as a driving force in tissue biological age. In practical terms, the result raises the possibility that an older donor heart may acquire some molecular characteristics associated with a younger environment after transplantation into a younger recipient. The authors describe this as possible rejuvenation of older organs and suggest that it could contribute to new approaches to organ allocation.
That implication remains a research direction rather than a change to transplant practice. The preprint reports mouse experiments and analyses of patients, but it does not test an age-based allocation strategy. Whether the observed molecular changes persist over time or translate into longer graft survival and better clinical outcomes requires further clinical study.
The work is presented as a bioRxiv preprint, so its findings are preliminary. The supplied abstract does not state the study populations’ sample sizes or follow-up duration, which limits assessment of the scale and persistence of the reported effect.